Cargando…

The case for a stratified application of targeted agents against pancreatic cancer

Detalles Bibliográficos
Autor principal:	Bijlsma, Maarten F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8099590/ https://www.ncbi.nlm.nih.gov/pubmed/33910122 http://dx.doi.org/10.1016/j.ebiom.2021.103344

Ejemplares similares

The contributions of hypoxia to poor outcomes in pancreatic cancer
por: Bijlsma, Maarten F.
Publicado: (2022)

Cancer stem cells: here, there, and everywhere
por: Lodestijn, Sophie C., et al.
Publicado: (2018)

Leukocyte phenotyping to stratify septic shock patients
por: McDunn, Jonathan E, et al.
Publicado: (2009)

What are the pros and cons of the use of host-targeted agents against hepatitis C?
por: Pawlotsky, Jean-Michel
Publicado: (2014)

Pediatric thyroid cancer guidelines: challenges in stratifying care based on limited data
por: Bauer, Andrew J, et al.
Publicado: (2022)

A PARP inhibitor in pancreatic cancer: Enhancement anti-tumour activity of chemoradiation therapy against pancreatic cancer?
por: Furuse, Junji
Publicado: (2019)

Developing CSCO Lung Cancer Practice Guidelines Stratified by Resource Availability and Treatment Value
por: Zhou, Qing, et al.
Publicado: (2016)

Pancreatic Cancer: Targeted Therapy Holds the Promise
por: Zhou, Zhijun, et al.
Publicado: (2021)

Targeting the hypoxia pathway to treat pancreatic cancer
por: Erickson, Lori A, et al.
Publicado: (2015)

ImmunoPET to help stratify patients for targeted therapies and to improve drug development
por: Kraeber-Bodere, Françoise, et al.
Publicado: (2016)

Cancer Stem Cells, EMT, and Developmental Pathway Activation in Pancreatic Tumors
por: Hindriksen, Sanne, et al.
Publicado: (2012)

Targeting tumour microenvironment, a FAKtual challenge in pancreatic cancer
por: Tolosa, Ezequiel J, et al.
Publicado: (2020)

Egg freezing, stratified reproduction and the logic of not
por: Ikemoto, Lisa C.
Publicado: (2015)

Can Urinary Complement Proteins Stratify Patients to Therapeutic Complement Inhibitors?
por: Medjeral-Thomas, Nicholas R.
Publicado: (2022)

Targeting the translational machinery to overcome apoptosis resistance in pancreatic cancer
por: Wirth, Matthias
Publicado: (2022)

Detection and Delineation of Oral Cancer With a PARP1-Targeted Optical Imaging Agent
por: Kossatz, Susanne, et al.
Publicado: (2017)

Moving beyond conventional stratified analysis to assess the treatment effect in a comparative oncology study
por: Sun, Ryan, et al.
Publicado: (2021)

Innovation Management? Orienting Sepsis R&D and Technology Transfer Towards Stratified Medicine
por: Özdemir, Vural, et al.
Publicado: (2016)

The hepatic pre-metastatic niche in pancreatic ductal adenocarcinoma
por: Houg, Demi S., et al.
Publicado: (2018)

Highly Effective Stratified Hub-and-Spoke Non-Pharmaceutical Intervention Provides New Insight into the Prevention of COVID-19 Transmission
por: Li, Hao, et al.
Publicado: (2020)

A Nanomedicine Approach to Manage Cancer – Imaging Pancreatic Cancer Using Targeted Iron Oxide Nanoparticles
por: Israel, Liron L.
Publicado: (2018)

Targeted Endocrine Agents should be the Dominant Systemic Therapies Prescribed in Luminal A Breast Cancer
por: Davey, Matthew G, et al.
Publicado: (2023)

The Cellular Origins of Cancer-Associated Fibroblasts and Their Opposing Contributions to Pancreatic Cancer Growth
por: Manoukian, Paul, et al.
Publicado: (2021)

Progress in stratified stroke characterization—associated with better diagnosis, accurate prognosis and improved treatment strategies
por: Slevin, Mark
Publicado: (2023)

ADAM9-Responsive Mesoporous Silica Nanoparticles for Targeted Drug Delivery in Pancreatic Cancer
por: Slapak, Etienne J., et al.
Publicado: (2021)

Stratifying Risk for Pancreatic Cancer by Multiplexed Blood Test
por: Digiacomo, Luca, et al.
Publicado: (2023)

Familial Pancreatic Cancer: To Screen or not to Screen?
por: Vasen, Hans F.A., et al.
Publicado: (2015)

An Overview of Artificial Intelligence Applications in Liver and Pancreatic Imaging
por: Cardobi, Nicolò, et al.
Publicado: (2021)

A Potent, Broad-Spectrum Antiviral Agent that Targets Viral Membranes
por: Wojcechowskyj, Jason A., et al.
Publicado: (2010)

Extracellular Influences: Molecular Subclasses and the Microenvironment in Pancreatic Cancer
por: Veenstra, Veronique L., et al.
Publicado: (2018)

MicroRNAs and long non-coding RNAs in pancreatic cancer: From epigenetics to potential clinical applications
por: Bravo-Vázquez, Luis Alberto, et al.
Publicado: (2022)

Activin in acute pancreatitis: Potential risk-stratifying marker and novel therapeutic target
por: Staudacher, Jonas J., et al.
Publicado: (2017)

Combining STAT3-Targeting Agents with Immune Checkpoint Inhibitors in NSCLC
por: Papavassiliou, Kostas A., et al.
Publicado: (2023)

Arguments against the Requirement of a Biological License Application for Human Pancreatic Islets: The Position Statement of the Islets for US Collaborative Presented during the FDA Advisory Committee Meeting
por: Witkowski, Piotr, et al.
Publicado: (2021)

Clinical Trials Targeting the Stroma in Pancreatic Cancer: A Systematic Review and Meta-Analysis
por: van Mackelenbergh, Madelaine G., et al.
Publicado: (2019)

Editorial: Translational Insights Into Pancreatic Ductal Adenocarcinoma
por: Bijlsma, Maarten F., et al.
Publicado: (2022)

Early macrophage infiltrates impair pancreatic cancer cell growth by TNF-α secretion
por: Tekin, Cansu, et al.
Publicado: (2020)

Targeting oncogenic SOX2 in human cancer cells: therapeutic application
por: Zhang, Shizhen, et al.
Publicado: (2019)

Speeding up the Evaluation of New Agents in Cancer
por: Parmar, Mahesh K. B., et al.
Publicado: (2008)

Can Localized Stenosis of the Main Pancreatic Duct be a Predictive Factor for Early Detection of Pancreatic Cancer?
por: Takenaka, Mamoru, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_s8hbjc6daadua5ia53hpd72ldb